ADAR1 Capital Management »

Greenlight Capital Re Ltd cl a shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Greenlight Capital Re Ltd cl a (GLRE) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Greenlight Capital Re Ltd cl a

Tip: Access up to 7 years of quarterly data

All positions including Greenlight Capital Re Ltd cl a held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Greenlight Capital Re Ltd cl a by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $167k 13k 12.47
2023-12-31 $389k 34k 11.42

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Greenlight Capital Re Ltd cl a

BlackRock
BlackRock
Dimensional Fund Advisors
Morgan Stanley
Vanguard Group
Private Management Group
Investec Asset Management
Orchard Capital Managment
Geode Capital Management
State Street Corporation
American Century Companies
CWA Asset Management
Deutsche Bank Aktiengesellschaft
Northern Trust
Goldman Sachs Group

View all funds holding Greenlight Capital Re Ltd cl a